These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16737665)

  • 1. Immunologic effects of mistletoe lectins: a placebo-controlled study in healthy subjects.
    Huber R; Rostock M; Goedl R; Lüdtke R; Urech K; Klein R
    J Soc Integr Oncol; 2006; 4(1):3-7. PubMed ID: 16737665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a lectin- and a viscotoxin-rich mistletoe preparation on clinical and hematologic parameters: a placebo-controlled evaluation in healthy subjects.
    Huber R; Klein R; Berg PA; Lüdtke R; Werner M
    J Altern Complement Med; 2002 Dec; 8(6):857-66. PubMed ID: 12614536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects.
    Huber R; Rostock M; Goedl R; Lüdtke R; Urech K; Buck S; Klein R
    Eur J Med Res; 2005 Oct; 10(10):411-8. PubMed ID: 16287602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.
    Klein R; Classen K; Berg PA; Lüdtke R; Werner M; Huber R
    Eur J Med Res; 2002 Apr; 7(4):155-63. PubMed ID: 12010650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of dendritic cells by an aqueous mistletoe extract and mistletoe lectin-3 in vitro.
    Stein GM; Büssing A; Schietzel M
    Anticancer Res; 2002; 22(1A):267-74. PubMed ID: 12017301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
    Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of mistletoe lectins and cytokines induced by them on cell proliferation of human melanoma cells in vitro.
    Thies A; Nugel D; Pfüller U; Moll I; Schumacher U
    Toxicology; 2005 Feb; 207(1):105-16. PubMed ID: 15590126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model.
    Elsässer-Beile U; Ruhnau T; Freudenberg N; Wetterauer U; Mengs U
    Cancer; 2001 Mar; 91(5):998-1004. PubMed ID: 11251952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of cellular and humoral immune responses during exposure of healthy individuals to an aqueous mistletoe extract.
    Stein GM; Berg PA
    Eur J Med Res; 1998 Jun; 3(6):307-14. PubMed ID: 9620894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immunomodulation and safety of standardized aqueous mistletoe extract PS76A2 in tumor patients treated for 48 weeks.
    Dohmen W; Breier M; Mengs U
    Anticancer Res; 2004; 24(2C):1231-7. PubMed ID: 15154652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients.
    Heiny BM; Beuth J
    Anticancer Res; 1994; 14(3B):1339-42. PubMed ID: 8067703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoactive effects of various mistletoe lectin-1 dosages in mammary carcinoma patients].
    Beuth J; Stoffel B; Ko HL; Buss G; Tunggal L; Pulverer G
    Arzneimittelforschung; 1995 Apr; 45(4):505-7. PubMed ID: 7779151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoprotective activity of the galactoside-specific mistletoe lectin in cortisone-treated BALB/c-mice.
    Beuth J; Ko HL; Tunggal L; Buss G; Jeljaszewicz J; Steuer MK; Pulverer G
    In Vivo; 1994; 8(6):989-92. PubMed ID: 7772751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Korean mistletoe lectin (KML-IIU) and its subchains induce nitric oxide (NO) production in murine macrophage cells.
    Kang TB; Yoo YC; Lee KH; Yoon HS; Her E; Kim JB; Song SK
    J Biomed Sci; 2008 Mar; 15(2):197-204. PubMed ID: 17940853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency of the common cold in healthy subjects during exposure to a lectin-rich and a lectin-poor mistletoe preparation in a randomized, double-blind, placebo-controlled study].
    Huber R; Klein R; Lüdtke R; Werner M
    Forsch Komplementarmed Klass Naturheilkd; 2001 Dec; 8(6):354-8. PubMed ID: 11799303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1.
    Beuth J; Ko HL; Tunggal L; Steuer MK; Geisel J; Jeljaszewicz J; Pulverer G
    In Vivo; 1993; 7(5):407-10. PubMed ID: 8110981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypereosinophilia induced by high-dose intratumoral and peritumoral mistletoe application to a patient with pancreatic carcinoma.
    Huber R; Barth H; Schmitt-Gräff A; Klein R
    J Altern Complement Med; 2000 Aug; 6(4):305-10. PubMed ID: 10976976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoactive action of mistletoe lectin-1 in relation to dose].
    Beuth J; Ko HL; Tunggal L; Buss G; Jeljaszewicz J; Steuer MK; Pulverer G
    Arzneimittelforschung; 1994 Nov; 44(11):1255-8. PubMed ID: 7848341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.